Hybrid Structure-Based Virtual Screening Protocol for the Identification of Novel BACE1 Inhibitors (original) (raw)
Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors
Armanda Santos
Biomolecules
View PDFchevron_right
Ensemble-Docking Approach on BACE-1: Pharmacophore Perception and Guidelines for Drug Design
Sandro Cosconati
ChemMedChem, 2007
View PDFchevron_right
Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors
Kader Sahin
Turkish Journal of Chemistry, 2020
View PDFchevron_right
Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening
Yi Mok
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
High-throughput virtual screening approach and dynamic simulation of natural compounds as target inhibitors of BACE1 in Alzheimer's disease
Fadoua Elkamili
View PDFchevron_right
Development of Dual Inhibitors against Alzheimer’s Disease Using Fragment-Based QSAR and Molecular Docking
Rabia Hamid
BioMed Research International, 2014
View PDFchevron_right
Fragment-based virtual screening approach and molecular dynamics simulation studies for identification of BACE1 inhibitor leads
Prabu Manoharan
Journal of Biomolecular Structure and Dynamics, 2017
View PDFchevron_right
Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents
Kunal Roy
Biosystems, 2014
View PDFchevron_right
Docking and scoring in virtual screening for drug discovery: methods and applications
Douglas Kitchen
Nature Reviews Drug Discovery, 2004
View PDFchevron_right
AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study
Georges Nemer
Methods in molecular biology (Clifton, N.J.), 2017
View PDFchevron_right
Virtual Screening for β-Secretase (BACE1) Inhibitors Reveals the Importance of Protonation States at Asp32 and Asp228
Tímea Polgár
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Determination of Potential Multi-Target Inhibitors of Alzheimer’s Disease in Silico
Glendalyn Boothe
2019
View PDFchevron_right
Fragment-based discovery and optimization of BACE1 inhibitors
Joachim Kraemer
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Virtual Screening and Admet Analysis for Identification of Inhibitors
Sunita Sharma
2014
View PDFchevron_right
In silico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design
IBRAHIM MOMOH
Network Modeling Analysis in Health Informatics and Bioinformatics, 2020
View PDFchevron_right
Structure modeling and hybrid virtual screening study of Alzheimer’s associated protease kallikrein 8 for the identification of novel inhibitors
SYED SHAHMIR AZAM
Medicinal Chemistry Research, 2014
View PDFchevron_right
Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
krishna kumar mishra
Molecules
View PDFchevron_right
Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R Grand Challenge 4
Leonardo Solis Vasquez
Journal of Computer-Aided Molecular Design, 2019
View PDFchevron_right
Acetylcholinesterase inhibitors selected by docking-based screening – proof-of-concept study
I Valkova
2018
View PDFchevron_right
Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays
Kader Sahin
Journal of Biomolecular Structure and Dynamics, 2019
View PDFchevron_right
Factors Influencing the Potency of Alzheimer Inhibitors: Computational and Docking Studies
Prof.Mohamed Awad
American journal of Alzheimer's disease and other dementias, 2018
View PDFchevron_right
Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
Fandi Sutanto
ChemMedChem, 2020
View PDFchevron_right
Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease
Bakhtiyor Rasulev
Molecules, 2023
View PDFchevron_right
Evaluation of Virtual Screening Strategies for the Identification of γ-Secretase Inhibitors and Modulators
Alicia Ioppolo
Molecules, 2021
View PDFchevron_right
Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors
Anuradha Kaplish
View PDFchevron_right
Benchmarking docking and scoring protocol for the identification of potential acetylcholinesterase inhibitors
Reaz Uddin
Journal of molecular graphics & modelling, 2010
View PDFchevron_right
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
harshita nigam
Journal of Biomedical Science, 2011
View PDFchevron_right
Identifying Potential Bace-1 Enzyme Inhibitors /Lead Small Molecules: Relevance to Alzheimer's Diseases
Deepak Ganesh
Zenodo (CERN European Organization for Nuclear Research), 2022
View PDFchevron_right
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Δ Β
The AAPS Journal, 2012
View PDFchevron_right
3D-pharmacophore model based virtual screening to identify dual-binding site and selective acetylcholinesterase inhibitors
shikhar gupta
Medicinal Chemistry Research
View PDFchevron_right
Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling
Sławomir Filipek
2014
View PDFchevron_right
Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease
Yajun Zheng
Journal of Medicinal Chemistry, 2013
View PDFchevron_right